University of Chicago
Chicago, Illinois, 60637, United States
NCT Number: NCT06078540
The purpose of this study is to test the proof-of-concept for adding a novel mHealth application, USeeBP, to the established UChicago Medicine Ambulatory Medicine Remote-Patient Monitoring (UCM-RPM) Hypertension Management Program in a population of African American adults with poorly controlled hypertension.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60637, United States
This is a single-arm, proof of concept study, which we will use to assess for initial evidence of efficacy and technical feasibility of adding the USeeBP mHealth app as an adjunct to the UCM-RPM program.
This study integrates the USeeBP app into the existing UCM-RPM clinical pathway. Regular UCM-RPM program activities include monitoring home blood pressure (BP) measurement flowsheets, performing patient telephone and EPIC MyChart message outreach, and making medication adjustments. USeeBP is a secure, chat-based smartphone application. The app connects to a patient's electronic BP cuff (eCuff) via Bluetooth and sends BP data to the UCM-RPM program (rather than using the companion app to the eCuff that is used in the UCM-RPM program). The USeeBP app also allows the patient to set BP check and medication reminders, as well as provides patient education and opportunities to participate in healthy behavior challenges.
The primary study goal is to measure the effect of the USeeBP mobile app on home BP. Serial home blood pressure measurements will be collected at multiple time points. We hypothesize that there will be a decrease in BP across the study period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
USeeBP is a low risk mobile medical app that proposes to do no more than:
Time frame: Baseline, Week 12
systolic pressure over diastolic pressure; measured by Bluetooth enabled, electronic, at home BP cuff
Time frame: Baseline, Week 12
measured by clinical BP cuff, BP control defined as clinically-measured BP < 140/90 mmHg
Time frame: Baseline, Week 12
measured by Medication Adherence Report Scale (MARS-5); minimum value is 5, maximum value is 25; lower values indicate worse medication adherence
Time frame: Week 12
total number of messages and replies
Time frame: Week 12
total number of visits
University of Chicago
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06560034
Blood Pressure, Cardiovascular Diseases
Breckenridge, Colorado, United States
View Trial DetailsNCT05062161
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT05472454
Blood Pressure, Cardiovascular Diseases
Spokane, Washington, United States
View Trial DetailsNCT06098092
Blood Pressure, Cardiovascular Diseases
Kladno, Czechia
View Trial Details